Identifying New Strategies to Optimize the Management and Treatment of COPDMannino, David M.Journal of Managed Care Medicine
Treatment and ManagementsDiagnosisSummary Chronic obstructive pulmonary disease (COPD) is a major global problem and its prevalence is increasing; yet under- or misdiagnosis is widespread, possibly due to clinical misinterpretation of symptoms, or lack of symptom reporting by patients....
*This is not a complete list of medications used for chronic obstructive pulmonary disease (COPD). † This is the only formulation of this specific combination of drugs approved by the Food and Drug Administration for tre...
Remdesivir, an antiviral agent, was the first drug to gain full FDA approval for treatment of hospitalized adults and adolescents with COVID-19 disease in October 2020. Since then, it has gained approval for adults and pediatric patients (birth who weigh at least 1.5 kg) with mild-to-moderat...
COPD chronic obstructive pulmonary disease DLQI Dermatology Life Quality Index HR hazard ratio IBD inflammatory bowel disease IL interleukin MACE major adverse cardiovascular events MI myocardial infarction NAFLD nonalcoholic fatty liver disease NMSC nonmelanoma skin cancer NPF National Psoriasis Foundation NSAI...
Cost-utility analysis of indacaterol in Germany: A once-daily maintenance bronchodilator for patients with COPD SummaryIntroduction Indacaterol is a novel inhaled once-daily long-acting beta2-agonist (LABA) for the maintenance treatment of COPD that has been compa... David,Price,and,... - 《Resp...
is provided to patients with persistent exacerbations or breathlessness despite treatment with a LAMA or LABA+ICS combination. Using data from The Health Improvement Network (THIN) primary care database, we aimed to describe trends in the management and outcomes of patients with COPD in UK general...
INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality in the world. Systematic treatment of CO... Dariusz Wiśniewski,M Porzezińska,Marta Gruchała-Niedoszytko,... - 《Pneumonol Alergol Pol》 被引量: 9发表: 2014年 Normas establ...
possibility of using a single device for maintenance and reliever treatment (82.4%). Conclusion According to pulmonologists, during the pandemic, treatments for COPD and asthma were mainly chosen on the basis of their ease of use; treatment adherence was good; and the number of remote visits ...
结果发生局限性自发性气胸的病人均有基础疾病,其中以重度慢性阻塞性肺疾病(COPD)病人为主,占所有病人的85。 2. Objective To investigate the evaluation of cardiopulmonary exercise test(CPET) in the patients with chronic obstructive pulmonary disease(COPD),and the relationship with the pulmonary function test...